Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mills

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters|February 9, 2011
The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritisChris De Savi, Andrew Pape, John G Cumming, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2019
Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995-1000]Maria B Goncalves, Earl Clarke, Christopher I Jarvis, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2019
Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injuryMaria B Goncalves, Earl Clarke, Christopher I Jarvis, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitorsMelanie S Glossop, Richard J Bazin, Kevin N Dack, et al.
European Heart Journal Open|June 12, 2025
Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trialGareth J Williams, Daniel J Taylor, Abdulaziz Al Baraikan, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters|February 9, 2011
The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritisChris De Savi, Andrew Pape, John G Cumming, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2019
Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995-1000]Maria B Goncalves, Earl Clarke, Christopher I Jarvis, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2019
Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injuryMaria B Goncalves, Earl Clarke, Christopher I Jarvis, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitorsMelanie S Glossop, Richard J Bazin, Kevin N Dack, et al.
European Heart Journal Open|June 12, 2025
Virtual physiological analysis of non-culprit disease in patients with STEMI and multivessel disease: a substudy of the COMPLETE trialGareth J Williams, Daniel J Taylor, Abdulaziz Al Baraikan, et al.
Pageof 3